Related Experiment Video
Updated: Jul 17, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Membranous nephropathy associated with fluconazole treatment
Gyu-Tae Shin1, Hyunee Yim, Jieun Park
1Department of Nephrology, Ajou University School of Medicine, Suwon, Korea. gtshin@ajou.ac.kr
This study reports the first case of membranous nephropathy caused by the antifungal drug fluconazole. The patient experienced recurrent nephrotic syndrome upon re-exposure to fluconazole, highlighting a new drug-induced kidney injury risk.
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Membranous nephropathy (MN) is a kidney disease often caused by drug exposure.
- Drug-induced MN accounts for 6-9% of all MN cases.
- Fluconazole, a common antifungal, has not been previously linked to MN.
Observation:
- A patient developed nephrotic syndrome.
- The nephrotic syndrome recurred upon re-administration of fluconazole.
- This suggests a causal link between fluconazole and membranous nephropathy.
Findings:
- This is the first reported case of drug-induced membranous nephropathy secondary to fluconazole.
- The patient experienced recurrent episodes of nephrotic syndrome upon fluconazole re-exposure.
- This case establishes fluconazole as a potential cause of membranous nephropathy.
Implications:
- Clinicians should consider fluconazole as a potential cause of membranous nephropathy.
- Further research is needed to understand the mechanism of fluconazole-induced MN.
- This finding expands the spectrum of known drug-induced kidney diseases.
Related Concept Videos
Cryptococcal Meningitis
Nephrotic Syndrome I : Introduction
Diabetic Nephropathy
Fungal Phylum Microsporidia
Cytomegalovirus Disease
Nephrons